SciSparc (SPRC)announced that MitoCareX Bio, its joint venture with Dr. Alon Silberman, is expanding its research and ...

TEL AVIV, Israel, Jan. 07, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage ...

Pancreatic cancer screening has advanced significantly in recent years. There are now research-based guidelines on screening ...

AMT-676 is under clinical development by Multitude therapeutics and currently in Phase I for Pancreatic Ductal Carcinoma.

Life without a pancreas involves treatments to replace organ function. Learn how different surgical techniques affect overall ...

Autologous SUPLEXA is under clinical development by Alloplex Biotherapeutics and currently in Phase I for Pancreatic Cancer.

In a compelling episode of "," Dr. John Marshall engages in a profound dialogue with Julie Fleshman, a vanguard in the realm ...

More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

Pancreatic cancer is a disease in which malignant ... the role of the tumour microenvironment and the microbiome in the development and progression of the disease, as well as on the promising ...

EDAP TMS (EDAP) announced that the first patient has been treated in a phase I/II PULS Trial sponsored by the Centre Leon Berard, Lyon, France, ...

pancreatic cancer represents a common target for pharmaceutical companies. Newer agents are in development with the promise of further refinement in treatment selection based on molecular tumor ...